Home › NDC Lookup › 63629-1134-01
⚪image loading
(from DailyMed)

Multivitamin with Fluoride .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D 2500 [iU]/1; 60 mg; 400 [iU]/1; 15 [iU]/1; 1.05 mg; 1.2 mg; 13.5 mg; 1.05 mg; 300 ug; 4.5 ug Tablet, Chewable, 100-count

by Bryant Ranch Prepack · 100 TABLET, CHEWABLE in 1 BOTTLE (63629-1134-1)
NDC 63629-1134-01
🏷️ FDA NDC (as labeled) 63629-1134-1 billing pads the package segment with a zero
Rx only On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 63629-1134-1
Product NDC 63629-1134
11-digit billing NDC 63629113401
NCPDP billing unit EA — each (per item)
UNII 81G40H8B0T, PQ6CK8PD0R, 9VU1KI44GP, WR1WPI7EW8, 8K0I04919X, TLM2976OFR +5 more
SPL Set ID 3c3acbdd-0bcb-4798-b6c5-242bdcd352b1
Established class (EPC) Vitamin A; Vitamin C; Nicotinic Acid; Vitamin B6 Analog; Vitamin B12
Chemical class Vitamin A; Ascorbic Acid; Nicotinic Acids; Vitamin B 6; Analogs/Derivatives; Vitamin B 12
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-07-20
Route ORAL
Dosage form TABLET, CHEWABLE
Substance VITAMIN A; ASCORBIC ACID; VITAMIN D; .ALPHA.-TOCOPHEROL ACETATE, DL-; THIAMINE MONONITRATE; RIBOFLAVIN; NIACIN; PYRIDOXINE; FOLIC ACID; CYANOCOBALAMIN; SODIUM FLUORIDE
GPI-14 78441000000505
GPI class Multivitamin/Fluoride
Why two NDCs? The FDA registers this code as 63629-1134-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 63629-1134-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerBryant Ranch Prepack
Labeler code63629
First marketedJul 2018
Product typeHuman Prescription Drug
Portfolio4,434 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is a chewable tablet containing a combination of vitamins and fluoride taken by mouth. It includes vitamin A and vitamin D for bone and immune support, vitamin C for collagen formation and antioxidant functions, and B vitamins (thiamine, riboflavin, niacin, vitamin B6, and vitamin B12) that typically help the body convert food into energy and maintain nerve function. The product also contains sodium fluoride, which is commonly used in dental products to support tooth strength. This product is marketed without an approved FDA application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color yellow
ShapeRound
ImprintM163
Size9 mm
ScoringNot scored
FlavorOrange
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 58657-0165-01 Method 100 tablets $0.098 — Availability likely —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 58657-0163-01 Method 100 tablets $0.102 — Availability likely —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 58657-0164-01 Method 100 tablets $0.105 — Availability likely —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ugthis 63629-1134-01 Bryant 100 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 72162-1656-01 Bryant 100 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 72162-1657-01 Bryant 100 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 63629-1135-01 Bryant 90 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 63629-1137-01 Bryant 90 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 63629-1138-01 Bryant 100 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 63629-1139-01 Bryant 90 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 72162-1655-01 Bryant 100 tablets — — FDA listed —
Multivitamin with Fluoride 2500 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.05 mg/1; 1.2 mg/1; 13.5 mg/1; 1.05 mg/1; 300 ug/1; 4.5 ug 63629-1136-01 Bryant 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2018
On the market since
Jul 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Multivitamin With Fluoride — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Multivitamin With Fluoride. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$343.82
Claims incl. refills
57
Beneficiaries
23
Spend / beneficiary
$14.95
Spend / claim
$6.03
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D — the ingredient across all brands.

Top reported reactions

Rash16
Fatigue15
Dizziness14
Dyspnoea14
Cough13
Arthralgia12
Flushing12

Age at onset

Child9
Adolescent6
Adult10
Elderly9

Reporter sex

213 reports
Male · 41%
Female · 59%

Serious outcomes

Hospitalization31
Death9
Disabling1
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 22 11
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
63629-1134-01 You're viewing this 100 TABLET, CHEWABLE in 1 BOTTLE (63629-1134-1) 2018-07-20 Active

🧭 About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 63629-1134-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 63629-1134-01, written without dashes as 63629113401. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 63629-1134-01, the first segment (63629) is the labeler code FDA assigned to Bryant Ranch Prepack; the middle segment (1134) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Bryant Ranch Prepack. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Bryant Ranch Prepack is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🤒 Adverse Reactions 🧬 Clinical Pharmacology 📦 How Supplied / Storage and Handling
🎯 Indications and Usage 201 words ▾

INDICATIONS AND USAGE Supplementation of the diet with ten essential vitamins. Supplementation of the diet with fluoride for caries prophylaxis. Multivitamin with Fluoride 0.25 mg Chewable Tablets provide 0.25 mg fluoride in tablet form for children 4-6years of age in areas where the drinking water contains 0.3 through 0.6 ppm of fluoride.

Multivitamin with Fluoride 0.25 mg Chewable Tablets supply significant amounts of Vitamins A, C, D, E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, and folate to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. Thus, in a single easy-to-use preparation, children obtain ten essential vitamins and the important mineral, fluoride. The American Academy of Pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplements.

Children using Multivitamin with Fluoride 0 . 25 mg Chewable Tablets regularly should receive semiannual dental examinations. The regular brushing of teeth and attention to good oral hygiene practices are also essential.

Multivitamin with Fluoride Chewable Tablets is a prescription product for the clinical dietary management of the metabolic processes of caries prophylaxis and provides supplementation of the diet with ten essential vitamins.

⏱️ Dosage and Administration 30 words ▾

DOSAGE AND ADMINISTRATION One tablet daily, to be dissolved in the mouth or chewed before swallowing. Do not give a chewable tablet to a child younger than 4 years old.

⚠️ Warnings 59 words ▾

WARNING Keep out of the reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately. CAUTION Do not eat or drink dairy products within one hour of fluoride administration. Should be chewed. This product, as all chewable tablets, is not recommended for children under age 4 due to risk of choking.

🤒 Adverse Reactions 11 words ▾

ADVERSE REACTIONS Allergic rash and other idiosyncrasies have been rarely reported.

🧬 Clinical Pharmacology 197 words ▾

CLINICAL PHARMACOLOGY It is well established that fluoridation of the water supply (1 ppm fluoride) during the period of tooth development leads to a significant decrease in the incidence of dental caries. Multivitamin with Fluoride 0 . 25 mg Chewable Tablets provide sodium fluoride and ten essential vitamins in a chewable tablet.

Because the tablets are chewable, they provide a topical as well as systemic source of fluoride. Hydroxyapatite is the principal crystal for all calcified tissue in the human body. The fluoride ion reacts with the hydroxyapatite in the tooth as it is formed to produce the more caries-resistant crystal, fluorapatite .

The reaction may be expressed by the equation: Ca10(PO4)6(OH)2 + 2F- ------- Ca10(PO4)6F2 + 2OH- (Hydroxyapatite) (Fluorapatite) Three stages of fluoride deposition in tooth enamel can be distinguished: 1. Small amounts (reflecting the low levels of fluoride in tissue fluids) are incorporated into the enamel crystals while they are being formed. 2.

After enamel has been laid down, fluoride deposition continues in the surface enamel. Diffusion of fluoride from the surface inward is apparently restricted. 3.

After eruption, the surface enamel acquires fluoride from the water, food, supplementary fluoride and smaller amounts from saliva.

📦 How Supplied / Storage and Handling 36 words ▾

HOW SUPPLIED Multivitamin Chewable tablets containing 0.25 mg fluoride are round yellowish/cream tablets with orange and yellow speckles. Debossed with “M163” on one side. NDC 63629-1134-1 (100 count) Repackaged/Relabeled by: Bryant Ranch Prepack Burbank, CA 91504

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 63629-1133-01 · Bryant 63629-1135-01 · Bryant →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.